FIELD: medicine.
SUBSTANCE: enzyme-immunoassay is used to measure blood plasma α-defensin (αD), ng/ml and fecal β-defensin (βD), ng/g and calprotectin (FC), mcg/g in the patients suffering inflammatory intestinal diseases; a probability of developing recurrent inflammatory intestinal disease (p), % is calculated by formula. If the derived probability is equal to 50% or more, a high risk of developing a recurrence is predicted, and if the probability is less than 50%, a low risk of developing the recurrence is predicted.
EFFECT: using the declared method enables the timely prediction of developing the recurrence of the inflammatory intestinal diseases.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF THERAPY OF ULCERATIVE COLITIS | 2024 |
|
RU2824983C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN ULCERATIVE COLITIS | 2012 |
|
RU2504779C1 |
| METHOD FOR PREDICTING THE RISK OF ULCERATIVE COLITIS RECURRENCE | 2021 |
|
RU2755492C1 |
| METHOD FOR DIAGNOSING MUSCULOSKELETAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASES | 2022 |
|
RU2790241C1 |
| METHOD OF TREATING AND PREVENTING GASTROINTESTINAL AND OTHER IMMUNODEFICIENT DISEASES WITH CHRONIC INFLAMMATORY SYNDROME | 2018 |
|
RU2708373C2 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF TERMINAL COLON | 2022 |
|
RU2807235C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY INTESTINAL CANAL DISEASES IN CHILDREN ACCORDING TO A SET OF CLINICAL, ANAMNESTIC, LABORATORY AND INSTRUMENTAL CRITERIA | 2020 |
|
RU2763258C1 |
| METHOD FOR DETERMINATION OF SEVERITY LEVEL OF ULCERATIVE COLITIS | 2007 |
|
RU2339956C1 |
| METHOD FOR DIAGNOSING DEGREE OF ACTIVITY OF ULCERATIVE COLITIS | 2023 |
|
RU2821756C1 |
| NON-INVASIVE DIAGNOSTIC TECHNIQUE FOR CHRONIC GASTRODUODENITIS IN CHILDREN | 2014 |
|
RU2574914C1 |
